Follow us on Twitter
Below you will find current and archived press releases for your associated company. Navigate by selecting the year in the list below and click on the press release you want to read. Distribution takes place with a maximum of five minutes delay from press release.
Gothenburg, Sweden, June 11, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel tr...
Gothenburg, Sweden. May 27, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) – a company discovering and developing novel tr...
Gothenburg, Sweden, May 23, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel tre...
Today, on Wednesday May 22, 2024, IRLAB Therapeutics AB held its Annual General Meeting.
The following ma...
Gothenburg, Sweden, May 22, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel tre...
Gothenburg, Sweden, May 22, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel tre...
Gothenburg, Sweden, May 21, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel tre...
Gothenburg, Sweden, May 8, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel trea...
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY
Gothenburg, Sweden, Ma...
Gothenburg, Sweden, May 6, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel trea...
Gothenburg, Sweden, May 6, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel trea...
Gothenburg, Sweden, April 29, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel t...
IRLAB Therapeutics AB, org.nr 556931-4692 (”IRLAB” eller ”Bolaget”), håller årsstämma onsdagen den 22 maj 2024 kl. 17.00 i Biotech c...
Gothenburg, Sweden, March 22, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel t...
Gothenburg, Sweden, 19 March 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel tr...
Gothenburg, Sweden, February 29, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing nove...
Gothenburg, Sweden, February 28, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing nove...
Gothenburg, Sweden, February 27, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing nove...
Gothenburg, Sweden, 22 February 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel...
Gothenburg, Sweden, February 7, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel...
Gothenburg, Sweden, February 6, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) is a company discovering and developing nov...
Gothenburg, Sweden, January 31, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel...
Gothenburg, Sweden, January 3, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel ...
